title: Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.
authors.forename: B
authors.initials: B
authors.lastname: Yazdani-Biuki
authors.forename: H
authors.initials: H
authors.lastname: Stelzl
authors.forename: H P
authors.initials: HP
authors.lastname: Brezinschek
authors.forename: J
authors.initials: J
authors.lastname: Hermann
authors.forename: T
authors.initials: T
authors.lastname: Mueller
authors.forename: P
authors.initials: P
authors.lastname: Krippl
authors.forename: W
authors.initials: W
authors.lastname: Graninger
authors.forename: T C
authors.initials: TC
authors.lastname: Wascher
mesh_terms: D000328:Adult; D000368:Aged; D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D007328:Insulin; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab